Practice of Medicine
Remain Alert to Black Box Warnings
According to the Institute of Safe Medication Practices (ISMP), lamotrigine (Lamictal®), an antiepileptic drug, led all other regularly monitored drugs in reports of severe cutaneous events in 2011.[i] The FDA has approved Lamictal for use as adjunctive therapy for partial seizures in children as young as 2 years. It is also approved as adjunctive therapy for generalized seizures in …
The information provided in this resource does not constitute legal, medical or any other professional advice, nor does it establish a standard of care. This resource has been created as an aid to you in your practice. The ultimate decision on how to use the information provided rests solely with you, the PolicyOwner.